Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus

Liraglutide is a glucagon-like peptide 1 (GLP-1) analog indicated for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise in adults. Liraglutide lowers blood glucose levels by stimulating insulin secretion and decreasing glucagon release in glucose-dependent manners, increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Micale, Sara J., Kane, Michael P., Hogan, Eileen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814067/
https://www.ncbi.nlm.nih.gov/pubmed/24222881
http://dx.doi.org/10.1155/2013/703925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814067/
https://www.ncbi.nlm.nih.gov/pubmed/24222881
http://dx.doi.org/10.1155/2013/703925

Ejemplares similares